# Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant

> **NCT03960008** · PHASE3 · TERMINATED · sponsor: **Lahey Clinic** · enrollment: 9 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- HCC

## Interventions

- **RADIATION:** Stereotactic Body Radiation Therapy (SBRT)
- **PROCEDURE:** Trans-Arterial Chemoembolization (TACE)
- **DRUG:** Doxorubin

## Key facts

- **NCT ID:** NCT03960008
- **Lead sponsor:** Lahey Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-03-01
- **Primary completion:** 2024-02-28
- **Final completion:** 2024-02-28
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** This study was closed early due to lack of enrollments and insufficient funding.
- **Last updated:** 2024-08-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03960008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03960008, "Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03960008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*